The measurement of metabolic variability over time, such as fluctuations in body weight, insulin levels, glucose levels, leptin levels, and adiponectin levels, may provide a more accurate tool for stratifying risk of endometrial cancer than traditional static measures. This evidence concerns the gene ADIPOQ and endometrial cancer.